An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes
Public ClinicalTrials.gov record NCT00960076. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
18-Week, Multicenter, Randomized, Double-Blind 3b Trial to Evaluate Efficacy/Safety of Saxagliptin in Combo With Metformin XR 1500mg vs Metformin Uptitrated to 2000mg in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control After Diet/Exercise and a Stable Dose of Metformin XR 1500mg
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare reduction in A1C for subjects taking Saxagliptin and Metformin XR vs. uptitrated Metformin XR.
Study identification
- NCT ID
- NCT00960076
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 282 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 78 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2009 (Type not available)
- Primary completion
- Oct 2010 (Actual)
- Completion
- Oct 2010 (Actual)
- Last update posted
- Sep 27, 2011
2009 – 2010
United States locations
- U.S. sites
- 22
- U.S. states
- 11
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Jonesboro | Arkansas | — | — |
| Research Site | Anaheim | California | — | — |
| Research Site | Fountain Valley | California | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | Pasadena | California | — | — |
| Research Site | Sacramento | California | — | — |
| Research Site | Gainesville | Florida | — | — |
| Research Site | Wellington | Florida | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Springfield | Illinois | — | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Salisbury | North Carolina | — | — |
| Research Site | Wilmington | North Carolina | — | — |
| Research Site | Winston-Salem | North Carolina | — | — |
| Research Site | Columbus | Ohio | — | — |
| Research Site | Marion | Ohio | — | — |
| Research Site | Simpsonville | South Carolina | — | — |
| Research Site | Bristol | Tennessee | — | — |
| Research Site | Alexandria | Virginia | — | — |
| Research Site | Burke | Virginia | — | — |
| Research Site | Manassas | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00960076, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2011 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00960076 live on ClinicalTrials.gov.